Things to Know about Karrueche Tran

The 26-year-old model Karrueche Tran has been trending on Social media. The Los Angeles born model is known for dating ‘Turn Up the Music’ artist Chris Brown. Tran came into light when it was disclosed that the American recording artist and dancer Chris is father of Tran’s baby girl.

Here are the some interesting things that people should know about her. Karrueche Tran was born in Los Angeles in 1988. The model had started dating the 25-year-old performer in 2010. According to some people familiar with the matter, Chris Brown’s relationship with Karrueche is the first serious relationship since his famous controversy with ‘If It's Lovin' That You Want’ singer Rihanna. As per some reports, the Disturbia singer also sympathizes with Karrueche.

Mental Care Is Not Merely a Policy, but a Cultural Issue, says Michelle Obama

The 'Changing Direction on Mental Health' campaign kicked off on Wednesday. The campaign was joined by more than forty organizations, including Montgomery County's Umttr. The participants of the campaign jointly pledge to change the story about mental health in the country.

It was found that Umttr and other local leaders partnered with 'Given an Hour', a non-profit organization founded to meet the mental health needs of military personnel and the event's main sponsor, at the launch of the campaign on March 4 at the Newseum in D. C.

Scientists report First Evidence of Human Adaptation to Arsenic

Researchers have noticed that people who lived high in Argentina's Andes Mountains for hundreds of years have been exposed to high levels of arsenic, which naturally occurs in their water.

Arsenic is a deadly chemical which can cause cancer and is mainly deadly for children and obstructs people's ability to reproduce.

During the study, published in the journal Molecular Biology and Evolution, researchers found that different people had different ability to metabolize and get rid of this fatal chemical.

In order to figure out the reason behind the variation, the researchers analyzed the genes which are a part of this detoxification process.

Rise in Percentage of Children eating Fruits in School: Study

A new study has shown positive effects of changes made to government-subsidized meals by the Obama administration to get schoolchildren eat more fruits. The Rudd Center for Food Policy and Obesity at the University of Connecticut conducted the study, showing a surge in the percentage of children eating fruits on cafeteria to 66% from 54%, since changes went into effect in 2012.

The study also showed that children were not wasting as much food as they were used to before the rules, which is another significant achievement.

Marlene B. Schwartz, the study's lead author and the director of the Rudd Center, said the study has highlighted the importance of nutrition standards for the National School Lunch Program to ensure healthy eating habits among students.

FDA gives nod to Bristol-Myers Squibb’s Opdivo

Bristol-Myers Squibb's drug Opdivo (nivolumab) has been approved by US Food and Drug Administration (FDA) for the treatment of lung cancer.

Opdivo was approved in December to treat advanced melanoma among people who don't respond to other medicines.

Now, FDA expanded its approval for patients with advanced squamous non-small-cell lung cancer (NSCLC) whose disease progressed during or after trying chemotherapy. The drug has been authorized for people who have been treated with platinum-based chemotherapy.

The decision to approve the drug came just weeks after clinical-trial results were available. The medicine is part of a class of drugs called immunotherapies that use patients' own immune systems to fight cancer.

FDA warns Doctors against over-prescribing Testosterone Drugs

According to reports, the United States Food and Drug Administration (FDA) has warned doctors against over-prescribing testosterone-boosting drugs for men. As per the federal agency of the United States Department of Health and Human Services, the treatments are not effective for common issues like fatigue and libido, which are age-related.

The agency said that drug-making companies should clear in their promotions and labeling that the drugs they are making which are taken by many men in the United States are approved to treat levels of low testosterone caused by an injury or disease.

Pages

News in Focus

HDFC Life Insurance Share Price Target at Rs 850: Emkay Global Research

Emkay Global has reaffirmed a BUY rating on HDFC Life Insurance, assigning a September 2026 target price of Rs 850.

Infosys Share Price Target at Rs 1,810: Choice Equity Broking Research Report

In its latest research, Choice Equity Broking maintains BUY recommendation on technology major Infosys, revising the target price to Rs 1,810—implying a potential upside of 25.7% from current level

CRED, Zerodha, Groww, Upstox, PAYTM Among Most Promising Fin-Techs from India

India’s fintech revolution has matured into a trillion-dollar opportunity by 2030, reshaping how hundreds of millions manage, borrow, invest, and insure their finances.

Biocon, Anthem Biosciences, Onesource Specialty Pharma and Sai Life Sciences Leading BioTech Innovation in India

India’s biotechnology industry, one of the fastest-expanding sectors globally, is blazing new trails across healthcare, pharmaceuticals, and sustainability.

Laurus Labs Share Price Target at Rs 1,110: Motilal Oswal Financial Services

Motilal Oswal Financial Services has reiterated its BUY call on Laurus Labs, highlighting a robust earnings trajectory and strategic capital deployment in CDMO and generics segments.

UltraTech Cement Share Price Target at Rs 14,406: Deven Choksey Research

Deven Choksey Research has reaffirmed a BUY call on UltraTech Cement, identifying significant growth drivers and robust financial resilience.